GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Solventum Corp (NYSE:SOLV) » Definitions » Net Income From Continuing Operations

SOLV (Solventum) Net Income From Continuing Operations : $720 Mil (TTM As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Solventum Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Solventum's net income from continuing operations for the three months ended in Sep. 2024 was $122 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Sep. 2024 was $720 Mil.


Solventum Net Income From Continuing Operations Historical Data

The historical data trend for Solventum's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solventum Net Income From Continuing Operations Chart

Solventum Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Net Income From Continuing Operations
1,138.00 1,460.00 1,343.00 1,346.00

Solventum Quarterly Data
Dec20 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 460.00 272.00 237.00 89.00 122.00

Solventum Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $720 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Solventum Business Description

Comparable Companies
Traded in Other Exchanges
Address
3M Center, St. Paul, MN, USA, 55144
Solventum Corp is an independent healthcare company with a primary focus on addressing healthcare challenges. Its diverse product portfolio spans the healthcare industry, including medical solutions, oral care, health information systems, and separation and purification sciences.